1. Valeant Pharma plans improved offer for Allergan

    Valeant Pharma plans improved offer for Allergan

    Botox maker Allergan said Valeant's uncertain long-term growth prospects and business model create a risk for its shareholders

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned

  3. Authors